Sec. 5. Annual report on research and development activities at USAID
256 words·~1 min read·
/bill/113/s/2407/is/section-5A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than 1 year after the date of the enactment of this Act, and annually thereafter for the following 4 years, the Administrator of the United States Agency for International Development, after consultation with the Centers for Disease Control and Prevention, the Department of Defense, the Food and Drug Administration, and the National Institutes of Health, shall submit a separate report to Congress on the research and development activities carried out by USAID. Each report submitted under subsection
(a)shall include— updates on the implementation of USAID's strategy for using research funds to stimulate the development and introduction of products in each of its global health and development programs; a description of USAID's collaborations and coordination with other Federal departments and agencies in support of translational and applied global health research and development; a description of USAID’s collaborations and coordination with partner governments, bilateral and multilateral donors, and other relevant governmental entities in support of translational and applied global health research and development; a description of USAID investments in science, technology, and innovation; an explanation of how technologies and research products developed by USAID complement work being done by other Federal departments and agencies; and a list of technologies and research products that have been introduced into field trials or use. The Administrator of USAID shall annually consult with the heads of other Federal departments and agencies to improve alignment of USAID's health-related research strategy with other similar agency strategies, with the intent of working towards a whole-of-government strategy for global health research and development.